Skip to main content

Table 1 Demographic features of participants and characteristics of headache experienced during the pandemic period

From: Headache characteristics in COVID-19 pandemic-a survey study

(n = 1968)

COVID-19 positivea

No COVID-19b

  

Prior headache (n = 116)

No prior headache (n = 87)

p

Prior headache (n = 138)

No prior headache (n = 383)

 

p (1–3)†

p (2–4)‡

Age year,mean (SD)

39.7 (11)

38.2 (11)

.370

41.0 (10)

42.2 (11)

.061

.175

.004

Sex (male %)

36.2

46.0

.104

22.9

31.6

.000

.001

.008

Healthcare worker (%)

44.0

43.7

.541

46.1

48.3

.239

.366

.255

Headache duration hours mean (SD)

52.1 (57)

45.3 (53)

.430

38.4 (53)

45.9 (63)

.039

.014

.949

Headache characteristics

 Pulsating %

50.9

32.5

.008

55.5

42.5

.000

.202

.064

 Pressing %

31.9

43.7

.058

29.0

38.6

.000

.289

.227

 Fiery %

2.6

2.3

.633

2.7

5.0

.022

.625

.219

 Stabbing %

12.9

16.1

.330

11.1

11.2

.497

.315

.142

Accompanying symptoms

 Nausea %

70.8

71.3

.538

53.5

52.9

.450

.000

.002

 Phonophobia %

67.0

67.9

.509

71.2

66.6

.056

.198

.465

 Photophobia %

63.9

63.0

.508

60.5

51.2

.002

.276

.038

 Osmophobia %

39.0

50.0

.090

30.4

28.5

.292

.044

.000

 Allodynia %

31.9

41.8

.024

 Anosmia/ageusia %

74.5

73.2

.479

19.1

23.1

.073

.000

.000

 Sore throat, rhinorrhea %

62.2

70.4

.152

41.8

54.4

.000

.000

.006

 Stinging, burning, tearing in the eyes

63.2

64.6

.481

44.8

49.8

.063

.000

.011

 Use of analgesics %

84.3

79.8

.257

82.8

69.8

.000

.389

.042

 No response to analgesics %

16.5

22.4

.227

7.1

8.0

.353

.002

.002

 Partial response to analgesics < 50%) %

38.1

38.8

.530

25.5

37.6

.000

.006

.484

 Improved with analgesics > 50%

32.0

25.4

.231

26.1

27.4

.362

.129

.436

 Completely recovered with analgesics %

12.4

11.9

.568

39.2

26.2

.000

.000

.008

  1. a Diagnosed by positive PCR test; b No COVID-19 symptoms or diagnosis; †p (1–3) p value between the patients with prior headache with or without positive COVID-19 test; ‡p (2–4) p value between the patients with no prior headache with or without positive COVID-19 test (significant test values are marked as bold)